Legato Capital Management LLC Raises Stock Position in Perrigo Company plc (NYSE:PRGO)

Legato Capital Management LLC boosted its holdings in Perrigo Company plc (NYSE:PRGO - Free Report) by 219.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,174 shares of the company's stock after acquiring an additional 22,798 shares during the quarter. Legato Capital Management LLC's holdings in Perrigo were worth $930,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its holdings in shares of Perrigo by 6,828.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,845,539 shares of the company's stock valued at $201,710,000 after buying an additional 7,732,309 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Perrigo by 0.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,989,530 shares of the company's stock valued at $179,698,000 after buying an additional 27,835 shares during the period. Deprince Race & Zollo Inc. lifted its holdings in shares of Perrigo by 1.1% during the 4th quarter. Deprince Race & Zollo Inc. now owns 4,557,844 shares of the company's stock valued at $117,182,000 after buying an additional 50,728 shares during the period. Ion Asset Management Ltd. lifted its holdings in shares of Perrigo by 50.1% during the 4th quarter. Ion Asset Management Ltd. now owns 2,820,000 shares of the company's stock valued at $72,502,000 after buying an additional 941,667 shares during the period. Finally, Copeland Capital Management LLC lifted its holdings in shares of Perrigo by 2.6% during the 1st quarter. Copeland Capital Management LLC now owns 2,452,786 shares of the company's stock valued at $68,776,000 after buying an additional 63,022 shares during the period. 95.91% of the stock is owned by institutional investors.

Perrigo Stock Performance

Shares of NYSE:PRGO traded down $0.28 during midday trading on Monday, hitting $28.15. The company had a trading volume of 199,815 shares, compared to its average volume of 1,403,460. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.36 and a quick ratio of 1.28. The company has a market cap of $3.87 billion, a price-to-earnings ratio of -21.46 and a beta of 0.45. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $30.93. The company has a fifty day moving average of $26.95 and a two-hundred day moving average of $26.22.

Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.56 by $0.04. Perrigo had a positive return on equity of 8.93% and a negative net margin of 4.16%. The firm had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same period in the prior year, the business posted $0.29 EPS. Perrigo's revenue was down 3.5% on a year-over-year basis. On average, equities research analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Friday, May 30th were paid a $0.29 dividend. The ex-dividend date of this dividend was Friday, May 30th. This represents a $1.16 dividend on an annualized basis and a yield of 4.12%. Perrigo's payout ratio is presently -88.55%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered Perrigo from a "buy" rating to a "hold" rating in a research note on Saturday. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.